Indication
de Novo
1 clinical trial
9 products
3 drugs
Clinical trial
A Phase I Study of Venetoclax in Combination With Cytotoxic Chemotherapy, Including Calaspargase Pegol, for Children, Adolescents and Young Adults With High-Risk Hematologic MalignanciesStatus: Recruiting, Estimated PCD: 2025-04-02
Product
VenetoclaxProduct
AzacitidineProduct
CytarabineProduct
MethotrexateProduct
HydrocortisoneDrug
mFOLFOX6Product
DexamethasoneDrug
VincristineProduct
DoxorubicinProduct
DexrazoxaneProduct
Calaspargase Pegol